Shoucheng Xie

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
GATA3 has been recognized as the novel marker for identifying primary and metastatic breast carcinomas, consistently showing that GATA3 was significantly more sensitive than traditional markers gross cystic disease fluid protein 15 (GCDFP15) and mammaglobin (MGB). However, clinically useful groups of breast carcinomas status were not identified, which were(More)
  • 1